| 000 | 00931nas a2200313 a 4500 | ||
|---|---|---|---|
| 003 | AR-LpU | ||
| 005 | 20240627181701.0 | ||
| 007 | ta | ||
| 008 | 230201d19621973xxu dr 000 0 eng d | ||
| 022 | _a0300-9637 | ||
| 024 | 8 |
_aDMD-M2020 _zDMD002024 |
|
| 040 |
_aAR-LpU _bspa _cAR-LpU |
||
| 245 | 0 | 0 | _aLife sciences. Part 2, Biochemistry, general and molecular biology |
| 260 |
_a: _b |
||
| 310 | _aQUINC | ||
| 362 | 0 | _a1962-73 | |
| 580 | _aFusionada con: <Life sciences. Part 1, Physiology and pharmacology> para formar <Life sciences>, 1973- | ||
| 650 | 4 |
_aBioquímica _9171558 |
|
| 650 | 4 |
_aBiología molecular _97436 |
|
| 650 | 4 |
_aCitología _930009 |
|
| 942 | _cCR | ||
| 999 |
_c957003 _d957003 |
||